340B Drug Pricing Program
340B Advocacy Alliance Bulletin for December 3, 2024.
AHA 340B Advocacy Alliance Bulletin - December 3, 2024.
The AHA Nov. 15 filed friend-of-the-court briefs in the U.S. Court of Appeals for the 5th Circuit in support of an earlier denial by the U.S. District Court for the Southern District of Mississippi of preliminary injunctions sought by Novartis and PhRMA against enforcement of the state's 340B…
AHA, Others Challenge Novartis in Court Filings to Defend Mississippi’s 340B Contract Pharmacy Law
AHA, others challenge Novartis in court filings to defend Mississippi’s 340B contract pharmacy law .
AHA, others challenge PhRMA in court filings to defend Mississippi’s 340B contract pharmacy law.
Johnson & Johnson Nov. 12 filed a lawsuit against the Department of Health and Human Services and the Health Resources and Services Administration asking a federal court in Washington, D.C., to declare J&J’s proposed 340B rebate model legal and block the government’s attempts to prohibit…
Johnson & Johnson yesterday filed a lawsuit against the Department of Health and Human Services and the Health Resources and Services Administration asking a federal court in Washington, D.C., to declare J&J’s proposed 340B rebate model legal and block the government’s attempts to prohibit…
The AHA Nov. 7 filed a friend-of-the-court brief in the U.S. District Court for the District of Kansas in defense of the state's law protecting against deceptive acts or practices related to 340B pricing for contract pharmacy arrangements.
AHA amicus brief defending Kansas’ 340B Contract Pharmacy Law in ABBVIE INC., et al., case.
AHA releases Regulatory Advisory summarizing CMS final guidance on implementation of the Medicare Drug Price Negotiation Program